Hereditary Fructose Intolerance
An inherited disorder of fructose metabolism caused by ALDOB gene variants, leading to toxic buildup of fructose-1-phosphate after fructose, sucrose, or sorbitol intake.
- Autosomal Recessive (ALDOB)
- Diagnosed via Genetic Testing
- Managed by Strict Dietary Avoidance
- Excellent Outlook with Early Diagnosis
- Inheritance Pattern
- Autosomal Recessive
- Gene Involved
- ALDOB
- Typical Onset
- Infancy (weaning)
- Core Management
- Lifelong Diet Control
- Specialist Support
- Metabolic Care Access
Condition Overview
Hereditary Fructose Intolerance (HFI) is an inherited metabolic disorder caused by variants in the ALDOB gene, which encodes the liver enzyme aldolase B. Without functional aldolase B, ingested fructose is converted to fructose-1-phosphate but cannot be broken down further, causing it to accumulate in the liver, kidney, and small intestine. This buildup disrupts energy production and can cause profound hypoglycemia, liver injury, and kidney dysfunction if fructose-containing foods are not avoided.
Symptoms typically appear when fructose-, sucrose-, or sorbitol-containing foods are introduced, often during weaning from breast milk or infant formula. With early recognition and strict lifelong dietary avoidance, individuals with HFI can lead healthy lives.
Forms and Variants
HFI does not have distinct clinical subtypes in the way some genetic disorders do. Instead, presentations vary based on the specific ALDOB variant inherited and the degree of residual enzyme activity, as well as how early fructose exposure is identified and removed from the diet.
Symptoms and Signs
Symptoms of HFI typically appear shortly after fructose-containing foods are introduced and can range from gastrointestinal distress to severe metabolic crisis.
Causes and Risk Factors
HFI is caused by inherited loss-of-function changes in the gene responsible for fructose breakdown in the liver.
Diagnosis and Investigations
Diagnosis of HFI combines a careful dietary history with biochemical and genetic testing, since symptoms can mimic other infantile feeding and liver disorders.
Severity Classification
HFI is not staged like cancer; instead, clinicians classify severity based on residual enzyme activity, timing of diagnosis, and degree of organ involvement at presentation.
Standard Management
There is no cure for HFI; management is centered on strict, lifelong dietary avoidance of fructose, sucrose, and sorbitol, paired with close monitoring of growth and organ function.
Specialized & Emerging Management Approaches
HFI does not have a disease-modifying drug or gene therapy in routine clinical use; management remains primarily nutritional. However, specialized centers and research are exploring ways to refine care and monitor long-term outcomes.
Nutritional Therapy
Individualized Metabolic Diet Planning
Specialist metabolic dietitians design diets that strictly exclude fructose, sucrose, and sorbitol while preventing micronutrient deficiencies common in fruit-restricted diets.
Monitoring Technology
Structured Liver & Renal Surveillance Programs
Periodic imaging and laboratory surveillance programs help detect early organ changes in patients with a history of delayed diagnosis.
Genetic Research
ALDOB Variant Functional Studies
Ongoing research into how specific ALDOB variants affect residual enzyme activity may eventually help refine individualized dietary thresholds.
Emerging Approaches
Enzyme & Gene-Based Strategies
Early-stage research into enzyme replacement or gene-based correction for inherited metabolic liver disorders is ongoing in the broader metabolic disease field, though none are yet approved for HFI specifically.
Relevant Laboratory Markers
While HFI is confirmed by genetic testing, several laboratory markers help assess organ involvement and guide ongoing monitoring.
When to Seek a Specialist Second Opinion
Because HFI is rare, a second opinion from a metabolic disease specialist can help confirm the diagnosis, refine dietary planning, and reassure families managing a lifelong condition.
Research and Clinical Studies
Outlook and Long-Term Management
With early diagnosis and consistent dietary avoidance of fructose, sucrose, and sorbitol, individuals with HFI generally have an excellent long-term outlook and normal life expectancy.
Supportive Care and Daily Living
Living well with HFI involves practical strategies for navigating food labels, medications, and everyday situations where hidden fructose may appear.
How CancerFax Helps You Explore Treatment Options
CancerFax can help you get a specialist review of genetic test results or growth concerns related to Hereditary Fructose Intolerance and connect you with experienced metabolic disease specialists.
Get a free case reviewFrequently Asked Questions
It is an inherited disorder caused by ALDOB gene variants that prevent the body from properly breaking down fructose, leading to toxic buildup in the liver, kidney, and intestine after fructose, sucrose, or sorbitol intake.
Vomiting, poor feeding, and failure to thrive after introducing fruit, juice, or sweetened formula are typically the earliest signs, usually appearing during weaning.
No. HFI is a serious enzyme deficiency requiring strict lifelong avoidance of fructose, sucrose, and sorbitol, while fructose malabsorption is a milder, unrelated digestive condition.
Diagnosis is typically confirmed through ALDOB genetic testing, supported by a history linking symptoms to fructose exposure and relevant laboratory findings.
There is no cure, but strict, lifelong dietary avoidance of fructose, sucrose, and sorbitol effectively prevents symptoms and allows normal growth and development.
Yes, milder cases are sometimes identified in adulthood, often after an unexplained reaction to intravenous fructose or sorbitol-containing fluids or medications.
Yes, HFI follows an autosomal recessive pattern, meaning a child must inherit a pathogenic ALDOB variant from each parent to be affected.
Fructose, sucrose (table sugar), and sorbitol must be avoided, which means eliminating most fruits, fruit juices, table sugar, honey, and many processed foods and sweeteners.
Parents of a child with HFI are both carriers, so future pregnancies carry a recurrence risk; genetic counseling can clarify this risk and discuss testing options.
Yes. CancerFax can help you submit genetic and laboratory reports for specialist review, request a second opinion on diagnosis or dietary management, and connect with metabolic disease specialists internationally for further guidance.
Get Expert Guidance on Hereditary Fructose Intolerance
Send your genetic or laboratory reports for specialist review and connect with metabolic disease experts to support your family's care plan.